-
From Phosphorylation Shift to Translational Insight
2026-08-30
Protein phosphorylation is often treated as a site-mapping problem, but translational decisions also depend on whether phosphorylation changes protein behavior, stability, and electrophoretic mobility. Using the WNK3–PER1 circadian study as an anchor, this article explains how Phosbind Acrylamide can help researchers connect kinase activity with phosphorylation-dependent protein states in accessible SDS-PAGE workflows—while clarifying what mobility shifts can and cannot prove.
-
MCC950 Sodium: From NLRP3 to Astrocyte Biology
2026-08-29
MCC950 sodium enables selective interrogation of NLRP3 signaling from macrophage cytokine release to spinal astrocyte phenotypes. This article translates recent morphine-tolerance findings into practical assay and autoimmune disease research decisions.
-
How Oxidative Stress Activates ATM: Structural Insights
2026-08-28
Howes, Perisic, and Williams reveal how hydrogen peroxide activates the ATM kinase through an interprotomer disulfide bridge and coordinated remodeling of the kinase domain. Their cryo-EM structure, supported by biochemical and kinetic experiments, explains how oxidative stress opens the substrate-binding site and enables ATM-mediated protein phosphorylation signaling.
-
Adamtsl3, MMP9, and Adult Cortical Plasticity
2026-08-28
The reference study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal-net integrity in parvalbumin-positive interneurons and connects its loss to excessive MMP9 activity, oxidative stress, and renewed adult cortical plasticity. These findings provide a mechanistic framework for studying how extracellular-matrix remodeling may contribute to schizophrenia-associated circuit dysfunction and for designing carefully controlled MMP9-focused experiments.
-
Bergenin Targets γδT17 Cells in Psoriasis
2026-08-27
A 2026 Phytomedicine study identifies a PPARγ–PROX1 pathway through which bergenin suppresses pathogenic γδT17-cell activity in psoriasis models. The work connects PPARγ-dependent K248-linked ubiquitination of PROX1 with reduced fatty acid oxidation, diminished IL-17A transcription, and improvement of psoriasiform dermatitis.
-
Cy5 TSA Fluorescence System Kit: Mechanism & Use
2026-08-27
The Cy5 TSA Fluorescence System Kit uses HRP-dependent tyramide deposition to amplify fluorescent detection in ICC, IHC, and FISH. The K1052 workflow provides a Cy5 readout at 648 nm excitation and 667 nm emission and is positioned for detection of low-abundance targets.
-
Apicidin: HDAC Inhibition, Uses, and Limits
2026-08-26
Apicidin is a natural histone deacetylase inhibitor with reported biochemical activity against HDAC3 and HDAC6. Evidence supports its use as a preclinical anti-proliferative and epigenetic research tool, while recent oocyte data establish important reproductive-toxicity limits.
-
Everolimus (RAD001) Assay Workflows
2026-08-26
Build more informative mTOR inhibition experiments with Everolimus (RAD001), combining pathway confirmation, proliferation measurements, and time-resolved cell-death analysis. This workflow helps distinguish cytostatic responses from true killing across cancer models while improving dose selection and troubleshooting.
-
Danazol: Mechanisms and Research Use
2026-08-25
Danazol is a weak androgenic steroid used in endocrine, steroidogenesis, and disease-model research. Evidence supports androgen-receptor engagement, suppression of LH-stimulated steroid production, and utility in rat models of precocious puberty, but these findings do not establish a universal clinical dose or efficacy.
-
Talabostat Mesylate (PT-100): DPP4/FAP Research
2026-08-25
Talabostat mesylate, also called PT-100 or Val-boroPro, is an orally active dipeptidyl peptidase inhibitor used to study DPP4 and FAP biology. Preclinical evidence supports target engagement in FAP-expressing breast cancer models, but reported in vivo tumor effects were modest and not statistically significant.
-
5-Azacytidine: Reliable Assay Design
2026-08-24
Learn how 5-Azacytidine (SKU A1907) can support reproducible viability, proliferation, and cytotoxicity workflows through mechanism-aware dosing, solvent control, and orthogonal readouts. This scenario-driven guide connects DNA methyltransferase inhibition with practical assay optimization and interpretation.
-
Stable-Isotope UHPLC–MS/MS for Methylated Nucleosides
2026-08-24
Zhang, Zhang, and Wang developed a stable isotope-diluted UHPLC–ESI-MS/MS method for measuring 12 purine ribonucleosides, including 10 methylated species such as 1-methyl Adenosine. Ammonium bicarbonate-assisted ionization, chromatographic isomer resolution, and methanol–SPE cleanup improved sensitivity sufficiently for intracellular measurements, creating a practical foundation for RNA modification research and nucleoside biomarker discovery.
-
(S)-(+)-Dimethindene maleate: M2 Workflow
2026-08-23
This practical guide explains how to use (S)-(+)-Dimethindene maleate as a research reagent for M2 muscarinic receptor antagonism while accounting for its additional H1 histamine receptor activity. It supports receptor-signaling, autonomic regulation, cardiovascular physiology, and respiratory studies, but it is not intended for diagnostic, therapeutic, or medical use.
-
Moxidectin–Polyene Synergy in Oral Candidiasis
2026-08-22
A 2024 study found that Moxidectin potentiates amphotericin B and nystatin against Candida albicans by increasing ergosterol biosynthesis, thereby strengthening polyene engagement with the fungal membrane. Genetic, biochemical, and mouse-model data support this repurposing strategy, while translational questions about exposure, safety, and clinical dosing remain open.
-
Proliferation Tracing Models Breast Cancer Relapse
2026-08-22
The reference study developed a dual recombinase PyMT mouse model that traces and ablates recently proliferating tumor cells, producing regression followed by relapse from residual low-cycling populations. Single-cell RNA sequencing showed that recurrent tumors were enriched for cancer stem cells, protumor γδ T cells, and myeloid programs associated with poor therapeutic response, establishing a useful platform for relapse biology and treatment testing.